Yang Yang
ABSTRACT
Population aging has become a global phenomenon. The aging population is in grim situation, and chronic disease prevalence rate is very high in China. In addition, the demand growth for medical service results in more home medication treatment. Therefore, drug undeserved risk for elderly patients also increases, which need more attention. In this paper, the problem of improper use of drugs for elderly people was investigated and analyzed, which could provide a reference for regulating the elderly family medication and reducing the risk of drug use. The questionnaire survey was conducted among 120 elderly people, and 83 of them were followed up. The elderly population in the family is not with standardized medication, over 60% of the elderly have strong randomness, inappropriate medication and safety hazards. Statistic difference existed between drug with long and short time for safety evaluation and. Irrational drug use can increase the adverse effects of drugs, which can cause some damage to the elderly health, and even increase the risk of death.
- Zhang, Q. and Han, C. 2007. Existence and Uniqueness of Strong Solutions for Stochastic Age-Dependent Population. Journal of Ningxia University, 30,4 (2007),1 51--161. Google Scholar
Digital Library
- Dou, J. W. and Li, K. T. 2006.Comparison Results for a Kind of Impulsive Parabolic Equations with Application to Population Dynamics. Acta Mathematicae Applicatae Sinica, 22,2(2006),211--218.Google ScholarCross Ref
- Neverova, G. P., Abakumov, A. I. and Yarovenko, I. P. et al. 2018. Mode change in the dynamics of exploited limited population with age structure. Nonlinear Dynamics, 5(2018),1--18.Google Scholar
- Khan, M. A. and Pavitra, N. 2009. Identifying a hidden problem---dementia---in elderly people living in old-age homes. Alzheimers & Dementia the Journal of the Alzheimers Association, 5,4 (2009), 390--390.Google ScholarCross Ref
- Wodarski, J. S. 2002. Utilizing Case Management to Maintain the Elderly in the Community. Journal of Gerontological Social Work, 39,4(2002), 19--38.Google ScholarCross Ref
- Wu, C.F. and Chen, F.Y. 2014. Case analysis of medication compliance in elderly patients. Chinese journal of tissue engineering research. B12, (Dec,2014), 7.Google Scholar
- Lv, D., Gao, C.Y., and Huang, W.L. 2009. Discussion about evaluation on post-marketing drug. Chinese Journal of Clinical Pharmacology. 25,2 (Mar,2009), 180--183.Google Scholar
- Hong, Q. and Chen, F. H. 2002. A study on the present condition of the household spare drugs in the residents of hefei city. Chinese Health Economics, 21,7(2002),21--22.Google Scholar
- Yang, B.F. 2008. Pharmacology. People's Health Publishing House. Beijing.Google Scholar
- Fan, Y., Chen, Y.H. and Liu, M.L. et al.2010. The therapeutic efficacy and safety of different statins in elderly. Chinese journal of geriatric heart brain and vessel diseases, 12,1(2010),3--5.Google Scholar
- Liu, J. Wang, W., and Liu, J. et al. 2013.Clustering of cardiovascular risk factors and hypertension control status among hypertensive patients in the outpatient setting. Chinese journal of cardiology. 41,12(2013),1050--1054.Google Scholar
- Van Werkum, J. W., Heestermans, A. A., Deneer, V. H., Hackeng, C. M., & Ten Berg, J. M. 2006. Clopidogrel resistance: fact and fiction. Future Cardiology. 2,2(2006), 215--228.Google ScholarCross Ref
- Shi, X.F., Huang, J.S., and Zhou, Y. L. et al. Research progress of shear force on thrombosis. Chinese journal of cardiology. 41, 10 (2013), 893--895.Google Scholar
- Zhu, B., and Zhao, Z.G.2016. Guarantee the safety the injection- the expert consensus on China intravenous injection treatment. Drug evaluation. 13,10(2016),8--17.Google Scholar
- Chinese expert consensus group studying in elderly abnormal blood lipids using stains. 2010. Chinese expert consensus studying statins in elderly with dyslipidemia. Chin H Intern Med, 49,6(Jul,2010),535--542.Google Scholar
- Wang, J.Q. 2015. Global recommendations interpretation on management of abnormal blood lipids by international atherosclerosis chemistry. Chinese Journal of Clinicians, 5(2015),15--17.Google Scholar
- Dahan, A., and Altman, H. 2004. Food-drug interaction: grapefruit juice augments drug bioavailability--mechanism, extent and relevance. European Journal of Clinical Nutrition, 58,1(2004), 1--9.Google ScholarCross Ref
- Yang, F. G. 2010. Analysis of potential drug safety problems in production of medical infusion and their countermeasures. China Safety Science Journal, 20,5(2010), 102--108.Google Scholar
- Li, X. H. 2012. Basic nursing. People's Health Publishing House. Beijing.Google Scholar
- Weems, C. F., Scott, B. G., Banks, D. M., & Graham, R. A. 2012. Is t.v. traumatic for all youths? the role of preexisting posttraumatic-stress symptoms in the link between disaster coverage and stress. Psychol Sci, 23,11(2012), 1293--1297.Google ScholarCross Ref
Index Terms
- Investigation and Research of the Hidden Dangers of Drug Misused in Elderly People
Recommendations
Social media mining for drug safety signal detection
SHB '12: Proceedings of the 2012 international workshop on Smart health and wellbeingAdverse Drug Reactions (ADRs) represent a serious problem all over the world. They may complicate a patient's medical conditions and increase the morbidity, even mortality. Drug safety currently depends heavily on post-marketing surveillance, because ...
A High Performance Agent-Based System for Reporting Suspected Adverse Drug Reactions
ITNG '12: Proceedings of the 2012 Ninth International Conference on Information Technology - New GenerationsAdverse drug reactions (ADRs) represent a serious worldwide problem. Current post-marketing ADR detection approaches largely rely on spontaneous reports filed by various healthcare professionals such as physicians, pharmacists et.al.. Underreporting is ...
Mining for Adverse Drug Events on Twitter
IC3K 2014: Proceedings of the International Joint Conference on Knowledge Discovery, Knowledge Engineering and Knowledge Management - Volume 1At the post-marketing phase when drugs are used by large populations and for long periods, unexpected adverse events may occur altering the risk-benefit relation of drugs, sometimes requiring a regulatory action. These events at the post-marketing phase ...
Comments